Trastuzumab in breast cancer - Reply

被引:0
|
作者
Mano, M
Cameron, D
Gelber, RD [1 ]
机构
[1] Inst Jules Bordet, B-1000 Brussels, Belgium
[2] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 06期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:642 / 643
页数:2
相关论文
共 50 条
  • [22] Clinical development of trastuzumab in breast cancer
    Tokuda Y.
    Ohta M.
    Suzuki Y.
    Kubota M.
    Tajima T.
    Breast Cancer, 2001, 8 (2) : 93 - 97
  • [23] Trastuzumab related cardiotoxicity in breast cancer
    Hsieh, Hui-Hsia
    Wu, Tien-Yuan
    Chen, Chi-Hua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 371 - 372
  • [24] Trastuzumab and capecitabine for metastatic breast cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1998, 40 (1039): : 106 - 108
  • [25] Gemcitabine and trastuzumab in metastatic breast cancer
    O'Shaughnessy, J
    SEMINARS IN ONCOLOGY, 2003, 30 (02) : 22 - 26
  • [26] Adjuvant trastuzumab in early breast cancer
    Mariani, G.
    Gianni, L.
    ANNALS OF ONCOLOGY, 2006, 17 : X54 - X58
  • [27] Mechanisms of Trastuzumab Resistance in Breast Cancer
    Tolaney, Sara M.
    Krop, Ian E.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (03) : 348 - 355
  • [28] Trastuzumab in the adjuvant treatment of breast cancer
    Svetlovska, D.
    Mardiak, J.
    Kristova, V
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2007, 108 (02): : 100 - 103
  • [29] Response of metastatic breast cancer to trastuzumab?
    Barnes, DM
    Miles, DW
    LANCET, 2000, 355 (9199): : 160 - 161
  • [30] Improving the efficacy of trastuzumab in breast cancer
    Suzuki, Eiji
    Toi, Masakazu
    CANCER SCIENCE, 2007, 98 (06) : 767 - 771